Cambridge, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Will Death in French Drug Trial Lead to Tighter Phase 1 Rules?

While regulators are trying to figure out what went wrong, independent chemists have dug into the mechanism of what may have been a "dirty" drug.
1-Feb-2016 10:05 AM EST Add to Favorites

Howard Feldman to Breathe New Life Into Alzheimer’s Network

The University of California San Diego’s incoming Alzheimer’s research czar talked with Alzforum about where he wants to take the embattled Alzheimer’s Disease Cooperative Study and neurodegeneration research in the region.
22-Jan-2016 11:05 AM EST Add to Favorites

ALS Meeting Upbeat on New Treatment Ideas and Experiments

While no cure is in sight, ALS experts see reason to feel hopeful about research progress and possible new treatments.
15-Jan-2016 4:05 PM EST Add to Favorites

Dementia with Lewy Bodies: Is the Research Ready for Clinical Trials

The most complicated of the age-relating dementing diseases just got a little clearer. Marked by degeneration of both the mind and the body, dementia with Lewy bodies combines aspects of both Alzheimer’s and Parkinson’s. DLB has for years...
22-Dec-2015 3:05 PM EST Add to Favorites

New Mice Help Scientists Understand ALS and Frontotemporal Dementia

Scientists have made several kinds of mice in the hope of mimicking ALS and frontotemporal dementia, diseases caused by mutations in the C9ORF72 gene. Early results indicate that the mutated genes generate unusual RNAs and proteins, but that losing...
7-Dec-2015 10:05 AM EST Add to Favorites

How Do You Communicate Alzheimer’s Risk in the Age of Prevention?

Researchers conducting clinical trials of drugs that might prevent AD are exploring how best to inform participants of their increased risk for the disease, and studying how they cope with this information. Alzforum reports in a two-part series.
11-Sep-2015 2:05 PM EDT Add to Favorites

100 DIAN Family Members Gather for Their First International Meeting

A sense of shared purpose energized a day of exchange between families with autosomal-dominant AD and researchers engaged in the Dominantly Inherited Alzheimer Network.
6-Aug-2015 4:05 PM EDT Add to Favorites

$100M IDEAS: CMS Blesses Study to Evaluate Amyloid Scans in Clinical Practice

The Centers for Medicare & Medicaid Services has given the nod to an 18,500-patient study to see whether amyloid scans prove their worth in the clinic. Researchers hope the study will eventually convince CMS and private insurance companies to cover...
17-Apr-2015 11:05 AM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.